Influence of biologic and conventional disease-modifying antirheumatic drugs on COVID-19 incidence among rheumatic patients during the first and second wave of the pandemic in Iran

INTRODUCTION: During the SARS-CoV-2 virus pandemic, immunosuppressive agents in treating chronic disease have become a concern, and rheumatic patients are not an exception. The controversies about the deteriorating effects of such medications led this study to evaluate the influence of biologic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahebari, Maryam, Mirfeizi, Zahra, Shariati-Sarabi, Zhaleh, Dadgar Moghadam, Malihe, Hashemzadeh, Kamila, Firoozabadi, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494785/
https://www.ncbi.nlm.nih.gov/pubmed/36186839
http://dx.doi.org/10.5114/reum.2022.119039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494785/
https://www.ncbi.nlm.nih.gov/pubmed/36186839
http://dx.doi.org/10.5114/reum.2022.119039

Ejemplares similares